Delayed adverse reactions in whole blood donors: Importance of active surveillance in identifying the missing gaps in the donor safety

被引:2
|
作者
Gupta, Abhaykumar [1 ]
Bajpai, Meenu [1 ,2 ]
机构
[1] Inst Liver & Biliary Sci, Dept Transfus Med, New Delhi, India
[2] Inst Liver & Biliary Sci, Dept Transfus Med, New Delhi 110070, India
关键词
Adverse donor reactions; blood donors; delayed reactions; donor safety; haematoma; vaso-vagal reactions; weakness; DONATION;
D O I
10.4103/ijmr.IJMR_1273_19
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background & objectives: The information available regarding delayed adverse donor reactions (D-ADRs) is limited. Proactive follow up of donors for delayed reactions is not done routinely. This study was undertaken to analyze frequency and type of D-ADRs in whole blood donors as also the contributory factors. Methods: In this prospective observational study, all eligible whole blood donors were contacted telephonically twice (24 h and 2 wks after donation) and asked about general health and ADR specific questions. The International Society of Blood Transfusion standard guidelines were used to categorize ADRs. Results: The ADR data of 3514 donors were analyzed in the study. D-ADRs were more common as compared to immediate delayed adverse donor reactions (I-ADRs) (13.7 vs. 2.9%, P<0.001). The most common D-ADRs were bruises (4.98%), fatigue or generalized weakness (4.24%) and sore arms (2.25%). D-ADRs were more common in first time donors as compared to the repeat blood donors (16.1 vs. 12.5%, P=0.002). Females were more prone to D-ADRs (17 vs. 13.6%). Localized D-ADRs were more frequent as compared to systemic D-ADRs (P<0.001). Repeat donors had a lower incidence of systemic D-ADRs (4.11% vs. 7.37%, P<0.001). Interpretation & conclusions: D-ADRs were more common than I-ADRs with a different profile. First time, female and young donors were more prone to D-ADRs. These categories need special care at the time of blood donation. Active follow up of blood donors should be done from time to time to strengthen donor safety.
引用
收藏
页码:30 / 36
页数:7
相关论文
共 33 条
  • [21] Prevalence and predictors of adverse reactions in plateletpheresis donors with the perspective of donor safety in a tertiary care hospital of Northern India
    Solanki, Archana
    Katharia, Rahul
    Singh, Ashutosh
    Chauhan, Abhishek
    Chandra, Tulika
    Sonker, Atul
    Agarwal, Prashant
    [J]. ASIAN JOURNAL OF TRANSFUSION SCIENCE, 2020, 14 (01) : 44 - 48
  • [22] Donor reactions among African-American and Caucasian first-time whole-blood donors
    Newman, BH
    Siegfried, BA
    Buchanan, LA
    [J]. TRANSFUSION, 2005, 45 (08) : 1398 - 1398
  • [23] Effect of a liberal versus a restrictive pre-donation blood pressure policy on whole-blood donor adverse reactions
    Salvadori, Ugo
    Sandri, Marco
    Cemin, Roberto
    Al-Khaffaf, Ahmad
    Daves, Massimo
    Maniscalco, Francesco
    Hueber, Rudolf
    Troi, Christina
    Griessmair, Astrid
    Ploner, Franz
    Egger, Karl
    Kuehebacher, Gottfried
    Gentilini, Ivo
    Vecchiato, Cinzia
    [J]. VOX SANGUINIS, 2019, 114 (04) : 317 - 324
  • [24] The International Haemovigilance Network Database for the Surveillance of Adverse Reactions and Events in Donors and Recipients of Blood Components: technical issues and results
    Politis, C.
    Wiersum, J. C.
    Richardson, C.
    Robillard, P.
    Jorgensen, J.
    Renaudier, P.
    Faber, J. -C.
    Wood, E. M.
    [J]. VOX SANGUINIS, 2016, 111 (04) : 409 - 417
  • [25] Post-donation telephonic interview of blood donors providing an insight into delayed adverse reactions: First attempt in India
    Tiwari, Aseem K.
    Aggarwal, Geet
    Dara, Ravi C.
    Arora, Dinesh
    Srivastava, Khushboo
    Raina, Vimarsh
    [J]. TRANSFUSION AND APHERESIS SCIENCE, 2017, 56 (02) : 141 - 146
  • [26] International Forum on Mitigation Strategies to Prevent Faint and Pre-faint Adverse Reactions in Whole Blood Donors: Responses
    Goldman, Mindy
    Townsend, Mary
    Magnussen, Karin
    Lozano, Miquel
    Nissen-Meyer, Lise Sofie H.
    Lee, Cheuk Kwong
    Leung, Jennifer Ngar-Sze
    Takanashi, Minoko
    McKay, Jennifer
    Kvist, Maria
    Robitaille, Nancy
    Deschenes, Jessyka
    Di Angelantonio, Emanuele
    McMahon, Amy
    Roberts, David
    Maghsudlu, Mahtab
    Castren, Johanna
    Tiberghien, Pierre
    Woimant, Genevieve
    Morel, Pascal
    Kamel, Hany
    Bravo, Marj
    Shinar, Eilat
    Gendelman, Veronica
    Raz, Hana
    Wendel, Silvano
    Fachini, Roberta
    Quee, Franke
    van den Hurk, Katja
    Wiersum, Jo
    Grima, Kathleen M.
    Speedy, Joanna
    Bruun, Mie Topholm
    Dunbar, Nancy M.
    [J]. VOX SANGUINIS, 2021, 116 (03) : E1 - E24
  • [27] Self-ignored onsite adverse donor reaction among whole blood donors: A single center experience from India
    Rajendran, Vinu
    Paonam, Bemma
    Chenna, Deepika
    Mohan, Ganesh
    Shastry, Shamee
    Jose, Prinu
    Kandasamy, Dhivya
    [J]. TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2022, 29 (02) : 124 - 128
  • [28] Analyses of Adverse Drug Reactions-Nationwide Active Surveillance Network: Canadian Pharmacogenomics Network for Drug Safety Database
    Tanoshima, Reo
    Khan, Amna
    Biala, Agnieszka K.
    Trueman, Jessica N.
    Drogemoller, Britt I.
    Wright, Galen E. B.
    Hasbullah, Jafar S.
    Groeneweg, Gabriella S. S.
    Ross, Colin J. D.
    Carleton, Bruce C.
    Rassekh, Shahrad R.
    Amstutz, Ursula
    Loucks, Catrina
    Higginson, Michelle
    Miao, Fudan
    Bendyshe-Walton, Tessa
    Trueman, Jessica N.
    McGoldrick, Nicole
    Biala, Agnieszka K.
    Khan, Amna
    Tanoshima, Miki
    Bhavsar, Amit P.
    Guilcher, Gregory
    Honcharik, Nick
    't Jong, Geert
    Israels, Sara
    Cuvelier, Geoff
    Staub, Michelle
    Rieder, Michael
    Faught, Lauren
    Ito, Shinya
    Nathan, Paul
    Karande, Smita
    Shear, Neil H.
    Vaillancourt, Regis
    Johnston, Donna
    Nguyen, Kimmy
    Bussieres, Jean-Francois
    Lebel, Denis
    Jean-Louis, Jennifer
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 59 (03): : 356 - 363
  • [29] Factors associated with vasovagal reactions in apheresis plasma and whole blood donors: a statistical-epidemiological study in a European donor cohort
    Seheult, Jansen N.
    Lund, Merete Eis
    Yazer, Mark H.
    Titlestad, Kjell
    [J]. BLOOD RESEARCH, 2016, 51 (04) : 293 - 296
  • [30] Vox Sanguinis International Forum on mitigation strategies to prevent faint and pre-faint adverse reactions in whole blood donors: Summary
    Goldman, Mindy
    Townsend, Mary
    Magnussen, Karin
    Dunbar, Nancy
    [J]. VOX SANGUINIS, 2021, 116 (03) : 351 - 359